glp 1 receptor agonists effects on cardiovascular risk reduction and mortality outcomes with GLP-1 vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Effects of Glucagon-Like Peptide 1

#GLP1RA use was linked to reduced steroid dependence, fewer hospitalizations, and improved durability of advanced #InflammatoryBowelDisease therapy, supporting further study in integrated metabolicIBD care

Novo's U.S.-listed shares dropped roughly 6%

Nutritional Considerations With Antiobesity Medications

These models were fitted separately for each of the data sources (ie, CDM, MarketScan, and Medicare) and for each drug comparison (SGLT-2 inhibitors v DPP-4 inhibitors, GLP-1 receptor agonists v DPP-4 inhibitors, and SGLT-2 inhibitors v GLP-1 receptor agonists), for a total of nine propensity score models

A., Rinella, M

Drug Deliv